Cefoperazone Sodium + Tazobactam SodiumThird Party Manufacturing in India

Cefoperazone Sodium + Tazobactam Sodium works by combining a broad-spectrum cephalosporin antibiotic with a potent beta-lactamase inhibitor. Cefoperazone sodium blocks bacterial cell wall synthesis by binding to penicillin-binding proteins. This inhibition disrupts the peptidoglycan cross-linking process, weakening the cell wall and causing cell lysis and death in growing bacteria. However, many bacteria produce beta-lactamase enzymes that hydrolyze the beta-lactam ring of cefoperazone, rendering it inactive. Tazobactam sodium is added to address this resistance. It binds irreversibly to beta-lactamases, particularly plasmid-mediated and chromosomal enzymes, preventing them from degrading cefoperazone. This synergistic combination restores the activity of cefoperazone against a wide range of gram-negative and gram-positive organisms, including beta-lactamase-producing strains. The combination behaves as a powerful bactericidal therapy suitable for severe systemic infections. It is especially useful in hospital-acquired infections where resistance is highly likely. Unlike carbapenems, this combination offers a targeted cephalosporin-based option that spares broader agents while achieving high clinical success rates.

Therapeutic Uses

Cefoperazone Sodium + Tazobactam Sodium is prescribed for the treatment of:

• Severe Respiratory Tract Infections: Used for community-acquired and hospital-acquired pneumonia, acute bronchitis, and lung abscesses.
• Complicated Urinary Tract Infections: Indicated for pyelonephritis, cystitis, and catheter-associated infections.
• Intra-abdominal Infections: Effective against peritonitis, cholecystitis, and other localized abdominal abscesses.
• Septicemia: Used to treat bacteremia and severe systemic infections.
• Skin and Soft Tissue Infections: Prescribed for complicated diabetic foot infections and surgical site infections.
• Gynecological Infections: Treats pelvic inflammatory disease, endometritis, and pelvic cellulitis.

Why Manufacturers Choose Cefoperazone Sodium + Tazobactam Sodium

Cefoperazone Sodium + Tazobactam Sodium is a high-demand combination in the institutional and hospital supply segments. With rising bacterial resistance, doctors frequently prescribe this combination as a first-line treatment for moderate to severe hospital infections before turning to reserve drugs. For third party manufacturers, this product offers stable commercial volumes and strong positioning in the sterile injectables portfolio. Indian manufacturers prefer it because of robust export demand and the presence of WHO-GMP certified facilities capable of handling sterile powder filling. This makes Cefoperazone Sodium + Tazobactam Sodium one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.